Literature DB >> 6289208

Clinical and virologic studies on female genital herpes.

T Kawana, K Kawagoe, K Takizawa, J T Chen, T Kawaguchi, S Sakamoto.   

Abstract

Ninety women with genital herpes were studied clinically and virologically. From a clinical standpoint, these patients could be classified into 3 clinical types--acute, recurrent, and provoked. When herpes simplex virus (HSV) strains isolated from these patients and asymptomatic virus secretors were typed, 36 strains were determined to be type 1 (HSV-1) and the remaining 54 to be type 2 (HSV-2). The acute type was caused by primary infection of HSV-1 or HSV-2 as well as by infection of HSV-2 in the absence of heterologous antibody. In addition, 35 of 40 HSV strains isolated from recurrent, provoked, and asymptomatic virus secretors were identified as HSV-2, suggesting that HSV-2 may play a major role in establishing latent infection in the female genital region.

Entities:  

Mesh:

Year:  1982        PMID: 6289208

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay.

Authors:  M Hashido; S Inouye; T Kawana
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

2.  Differentiation of primary from nonprimary genital herpesvirus infections by detection of polymeric immunoglobulin A activity.

Authors:  M Hashido; T Kawana; S Inouye
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

3.  Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and a phorbol ester.

Authors:  D Gius; L A Laimins
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

Review 4.  [Infections with herpes simplex and varicella-zoster viruses during pregnancy].

Authors:  R Marculescu; L Richter; K Rappersberger
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

5.  Prevention and control of herpesvirus diseases. Part 2. Epidemiology and immunology.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.